VANGUARD GROUP INC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 15 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$389,000
-27.4%
1,112,8950.0%0.00%
Q3 2019$536,000
-22.3%
1,112,895
-3.4%
0.00%
Q2 2019$690,000
+6.3%
1,152,175
+15.9%
0.00%
Q1 2019$649,000
+11.1%
994,175
+36.4%
0.00%
Q4 2018$584,000
-47.1%
728,730
-28.8%
0.00%
Q3 2018$1,105,000
-54.3%
1,023,533
+2.5%
0.00%
Q2 2018$2,416,000
+18.3%
998,233
+1.6%
0.00%
Q1 2018$2,043,000
+6.7%
982,328
+32.4%
0.00%
Q4 2017$1,915,000
+120.1%
742,199
+21.1%
0.00%
Q3 2017$870,000
+6.0%
612,6410.0%0.00%
Q2 2017$821,000
+37.3%
612,641
+52.6%
0.00%
Q1 2017$598,000
+2035.7%
401,530
+647.5%
0.00%
Q4 2016$28,000
-62.7%
53,7190.0%0.00%
Q3 2016$75,000
-50.3%
53,719
-38.6%
0.00%
Q2 2016$151,000
-29.8%
87,4740.0%0.00%
Q1 2016$215,000
-17.0%
87,4740.0%0.00%
Q4 2015$259,000
-99.7%
87,474
-96.4%
0.00%
-100.0%
Q3 2015$88,087,000
+19345.3%
2,457,897
+4199.0%
0.00%
Q2 2015$453,00057,1740.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 4,859,885$11,955,0000.64%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$246,0000.00%
Alyeska Investment Group, L.P. 143,985$354,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 31,792$78,0000.00%
Geneva Advisors, LLC 12,500$31,0000.00%
BlackRock Investment Management, LLC 846$2,0000.00%
MORGAN STANLEY 500$1,0000.00%
BlackRock Institutional Trust Company, N.A. 28,379$70,0000.00%
Walleye Trading LLC 700$2,0000.00%
LPL Financial LLC 61,246$131,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders